GL1X · GenesisL1 explorer

UniProt P04150

Glucocorticoid receptor (P04150)

Glucocorticoid receptor (UniProt P04150): 102 experimental structures and 1 predicted model on GenesisL1, 16 ligands bound, 105 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
P04150
Protein
Glucocorticoid receptor
Experimental structures
102
Predicted models
1
Ligands
16
Pockets
105 · 24 records with a druggable one

Structures

103 records of P04150 in the MolNFT archive: 102 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1M2ZCrystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain…x-ray diffractionA, D——
1M2ZCrystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain…x-ray diffractionA, D——
1NHZCrystal Structure of the Antagonist Form of Glucocorticoid Receptorx-ray diffractionA——
1NHZCrystal structure of the antagonist form of glucocorticoid receptorx-ray diffractionA——
1P93Crystal structure of the agonist form of glucocorticoid receptorx-ray diffractionA, B, C, D——
1P93Crystal structure of the agonist form of glucocorticoid receptorx-ray diffractionA, B, C, D——
3BQDDoubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazolx-ray diffractionA——
3BQDDoubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazolx-ray diffractionA——
3CLDLigand binding domain of the glucocorticoid receptor complexed with fluticazone furoatex-ray diffractionA, B——
3CLDLigand binding domain of the glucocorticoid receptor complexed with fluticazone furoatex-ray diffractionA, B——
3E7CGlucocorticoid Receptor LBD bound to GSK866x-ray diffractionA, B——
3E7CGlucocorticoid receptor lbd bound to GSK866x-ray diffractionA, B——
3H52Crystal structure of the antagonist form of human glucocorticoid receptorx-ray diffractionA, B, C, D——
3H52Crystal structure of the antagonist form of human glucocorticoid receptorx-ray diffractionA, B, C, D——
3K22Glucocorticoid Receptor with Bound alaninamide 10 with TIF2 peptidex-ray diffractionA, B——
3K22Glucocorticoid receptor with bound alaninamide 10 with TIF2 peptidex-ray diffractionA, B——
3K23Glucocorticoid Receptor with Bound D-prolinamide 11x-ray diffractionA, B, C——
3K23Glucocorticoid receptor with bound D-prolinamide 11x-ray diffractionA, B, C——
4CSJThe discovery of potent selective glucocorticoid receptor modulators, suitable for inhalationx-ray diffractionA——
4CSJThe discovery of potent selective glucocorticoid receptor modulators, suitable for inhalationx-ray diffractionA——
4HN5GR DNA Binding Domain - TSLP nGRE Complexx-ray diffractionA, B——
4HN5Gr DNA binding domain - tslp ngre complexx-ray diffractionA, B——
4HN6GR DNA Binding Domain R460D/D462R - TSLP nGRE Complexx-ray diffractionA, B——
4HN6Gr DNA binding domain R460D/D462R - tslp ngre complexx-ray diffractionA, B——
4LSJCrystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Bound to a Dibenzoxapine…x-ray diffractionA——
4LSJCrystal structure of the glucocorticoid receptor ligand binding domain bound to a dibenzoxapine…x-ray diffractionA——
4MDDCrystal Structure of the Glucocorticoid Receptor Bound to a Non-steroidal Antagonist Reveals…x-ray diffractionA, B——
4MDDCrystal structure of the glucocorticoid receptor bound to a non- steroidal antagonist reveals…x-ray diffractionA, B——
4P6WCrystal Structure of mometasone furoate-bound glucocorticoid receptor ligand binding domainx-ray diffractionA——
4P6WCrystal structure of mometasone furoate-bound glucocorticoid receptor ligand binding domainx-ray diffractionA——
4P6XCrystal Structure of cortisol-bound glucocorticoid receptor ligand binding domainx-ray diffractionA, C, E, G, I, K——
4P6XCrystal structure of cortisol-bound glucocorticoid receptor ligand binding domainx-ray diffractionA, C, E, G, I, K——
4UDCGR in complex with dexamethasonex-ray diffractionA——
4UDCGr in complex with dexamethasonex-ray diffractionA——
4UDDGR in complex with desisobutyrylciclesonidex-ray diffractionA——
4UDDGr in complex with desisobutyrylciclesonidex-ray diffractionA——
5CC1S425G glucocorticoid receptor DNA binding domain - (+)gre complexx-ray diffractionA, B, W, X——
5E69Glucocorticoid receptor DNA binding domain - IL8 NF-kB response element complexx-ray diffractionA, BZN—
5E69Glucocorticoid receptor DNA binding domain - IL8 nf-kb response element complexx-ray diffractionA, B——
5E6AGlucocorticoid receptor DNA binding domain - PLAU NF-kB response element complexx-ray diffractionA, BZN2 (best 0.68)
5E6AGlucocorticoid receptor DNA binding domain - plau nf-kb response element complexx-ray diffractionA, B——
5E6BGlucocorticoid receptor DNA binding domain - RELB NF-kB response element complexx-ray diffractionA, BZN3 (best 0.69)
5E6BGlucocorticoid receptor DNA binding domain - relb nf-kb response element complexx-ray diffractionA, B——
5E6CGlucocorticoid receptor DNA binding domain - CCL2 NF-kB response element complexx-ray diffractionA, BZN—
5E6CGlucocorticoid receptor DNA binding domain - CCL2 nf-kb response element complexx-ray diffractionA, B——
5E6DGlucocorticoid receptor DNA binding domain - ICAM1 NF-kB response element complexx-ray diffractionA, BZN3 (best 0.69)
5E6DGlucocorticoid receptor DNA binding domain - ICAM1 nf-kb response element complexx-ray diffractionA, B——
5EMCTranscription factor GRDBD and smGRE complexx-ray diffractionA, BZN—
5EMCTranscription factor grdbd and smgre complexx-ray diffractionA, B——
5EMPTranscription factor GRDBD and mmGRE complexx-ray diffractionA, BZN—
5EMPTranscription factor grdbd and mmgre complexx-ray diffractionA, B——
5EMQTranscription factor GRDBD and GRE complexx-ray diffractionA, BZN—
5EMQTranscription factor grdbd and gre complexx-ray diffractionA, B——
5G3JDiscovery of New Selective Glucocorticoid Receptor Agonist Leadsx-ray diffractionACPS, E7T—
5G3JDiscovery of new selective glucocorticoid receptor agonist leadsx-ray diffractionA——
5G5WStructure guided design and discovery of Indazole ethers as highly potent, non-steroidal…x-ray diffractionAR8C2 (best 0.83)
5G5WStructure guided design and discovery of indazole ethers as highly potent, non-steroidal…x-ray diffractionA——
5NFPGlucocorticoid Receptor in complex with budesonidex-ray diffractionACPS, 8W52 (best 0.85)
5NFPGlucocorticoid receptor in complex with budesonidex-ray diffractionACPS, 8W5—
5NFTGlucocorticoid Receptor in complex with AZD5423x-ray diffractionA8W8—

43 records more on the page itself.

Ligands

  • ZN · Zinc ion · in 24 records
  • DEX · Dexamethasone · in 4 records
  • CPS · 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate · in 3 records
  • 486 · 11-(4-dimethylamino-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one · in 2 records
  • 82H · Velsecorat · in 2 records
  • 8W5 · (1~{S},2~{S},4~{R},6~{R},8~{S},9~{S},11~{S},12~{S}, 13~{R})-9,13-dimethyl-11-oxidanyl-8-(2-oxidanylethanoyl)-6-propyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13, 18}]icosa-14,17-dien-16-one · in 2 records
  • 8W8 · 2,2,2-tris(fluoranyl)-~{N}-[(1~{R},2~{S})-1-[1-(4-fluorophenyl)indazol-5-yl]oxy-1-(3-methoxyphenyl) propan-2-yl]ethanamide · in 2 records
  • B9Q · ~{N}-[(1~{R},2~{S})-1-[1-(4-fluorophenyl)indazol-5-yl]oxy-1-(6-methoxypyridin-3-yl)propan-2-yl]cyclopropanecarboxamide · in 2 records
  • B9T · ~{N}-[(1~{R},2~{S})-1-(2-bromanyl-4-cyano-phenoxy)-1-(2-cyclopropylpyrimidin-5-yl)propan-2-yl]-2,2-bis(fluoranyl)propanamide · in 2 records
  • B9W · 2,2-bis(fluoranyl)-~{N}-[(1~{R},2~{S})-3-methyl-1-[1-(1-methyl-6-oxidanylidene-pyridin-3-yl)indazol-5-yl]oxy-1-phenyl-butan-2-yl]propanamide · in 2 records
  • HJ4 · (8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-(3,3-dimethylbut-1-yn-1-yl)-17-hydroxy-13-methyl-1,2, 6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name) · in 2 records
  • A1ACE · (4aR,4bS,5R,6aS,6bS,8R,9aR,10aR,10bR)-8-{4-[(3-aminophenyl)methyl]phenyl}-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one · in 1 record
  • E7T · 5-[[(1S,2R,4R)-4-ethyl-6,7-bis(fluoranyl)-2,5-bis(oxidanyl)-2-(trifluoromethyl)-3,4-dihydro-1H-naphthalen-1-yl]amino]-1H-quinolin-2-one · in 1 record
  • GW6 · (6alpha,11alpha,14beta,16alpha,17alpha)-6,9-difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-16-methyl-3-oxoan drosta-1,4-dien-17-yl furan-2-carboxylate · in 1 record
  • QJK · 5-[(2~{R})-3-(4-chlorophenyl)carbonyl-2-(4-nitrophenyl)-4-oxidanyl-5-oxidanylidene-2~{H}-pyrrol-1-yl]-2-oxidanyl-benzoic acid · in 1 record
  • R8C · 2,2,2-trifluoro-N-[(1R,2S)-1-{[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy}-1-phenylpropan-2-yl]acetamide · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.